Improving the “wait and see” approach to treatment for high-risk blood cancer

Publish Date: 28/8/2017

Australian researchers utilising valuable samples from an initial clinical trial funded with the help of Leukaemia Foundation supporters have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.

Quick Links

For Media

Privacy

Your privacy is important to us - that is why we treat your personal information with confidence. To learn more about how and why we collect and use any personal or sensitive information about you, please read our notification statement